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INTRODUCTION 
 
                    Jaundice or icterus a generic term used for yellowish 
discoloration of the skin, mucous membrane or sclera caused by a 
heterogeneous group of disorders. It is useful to divide the causes of 
obstructive jaundice into two categories, cholestasis from 
parenchymal liver disease and mechanical obstruction from a block of 
the intrahepatic or extrahepatic biliary tract. 
                Surgical jaundice or Obstructive jaundice occurs due to the 
intra or extra hepatic obstruction to the biliary flow. 
 It can present as a problem in diagnosisand management because 
there is a group of jaundiced patients in whom it is very difficult to 
distinguish between organic / Structural obstruction and a medical 
cause of jaundice particularly intrahepatic cholestasis. 
Biliary obstruction produces local effects on the bile ducts that lead to 
derangements of hepatic function and ultimately to widespread 
systemic effects. 
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            Patients with complete biliary obstruction have clinical 
jaundice, whereas patients with intermittent biliary obstruction may 
present with pain, pruritus, fevers and biochemical changes without 
developing clinical jaundice. Patients with chronic incomplete 
obstruction eventually can develop hepatic fibrosis and biliary 
cirrhosis.  
Two third of casesof obstructive jaundice are caused by 
congenital and benign diseases like calculus diseases of biliary tract, 
Choledochol cyst, pancreas divisum, annular pancreas, primary 
sclerosing cholangitis and post-operative or post pancreatitis 
strictures.  
Malignant diseases like carcinoma head of pancreas, 
Periampullary carcinoma, and cholangiocarcinoma and gall bladder 
malignancies are responsible for the rest. 
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AIM OF STUDY 
 
1. To study the incidence of causes of obstructive jaundice in our  
hospital. 
2. To study the age of presentation and sex distribution. 
3. To study various clinical presentations. 
4. To evaluate various management modalities. 
5. To study the complications associated with obstructive jaundice 
and its management. 
6. To analyse the histopathology of resected specimen. 
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REVIEW OF LITERATURE I 
 
Jaundice is a generic term, which describes yellow 
discolouration of skin, sclera or mucous membrane. 
Mention of jaundice is made in the words of Hippocrates (400 
BC) who pointed out that persistent jaundice may be due to carcinoma 
or cirrhosis of liver. Gall stones have been described in Chilean 
mummies since the second and third centuries AD. Galen in second 
century AD in his humoral concept of the disease attributed 
abnormalities of yellow bile, black bile, blood and phlegma within the 
body to cause disease. 
• Francis Glisson (1640), Abrahmson Vater (1720) and 
Ruggero Oddi (1887) refined anatomy with description of 
sphincteric mechanics. 
• Charcot (1877) discussed the symptoms associated with 
the passage of CBD stones which were jaundice, pain 
abdomen and fever (Charcot triad). 
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• Telfer Reynold added hypotension and altered mental 
status to Charcot’s triad (Reynolds’s pented) related to 
sepsis and cholangitis. 
• Langenbunch performed first cholecystectomy in the year 
1882. 
• Robert Abbe (1889) was the first to performed 
choledochotomy. 
• Lawson Trait performer Choledocholithotomy. 
• Ludwig Courvoisier (1843-1918) states Courvoisier’s law. 
Courvoisier Law: 
             In obstruction of the common bile duct due to a stone, 
distension of the gallbladder seldom occurs; the organ usually is 
already shrivelled. In obstruction from other causes the distension is 
common. If there is no disease of gall bladder and the obstruction is 
due to a cancer of ampulla, pancreas and bile duct, then the gall 
bladder well may well distended. 
• William Stewart Halstead performed 
Choledochoduodenal anastomosis for ampullary 
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Carcinoma. 
• Emil Theodor Kocher’s introduced Kocher incision and 
Kochermaneuverer. 
• Charles Mcburney- Tran’s duodenal Choledochotomy. 
• Hans Kehr – Invented T-tube 
• John B murphy – Cholecystoenterostomy avoiding 
choledochotomy 
• The first mention of carcinoma gall bladder was published 
in 1777 in Ratio Mendendi of maximillian stall. 
• Fredrich discussed Carcinoma gall bladder and suggested 
the relationship between gall bladder stone and cancer. 
• Graham Cole (1925)- Oral cholecystography. 
• Mirrizzi (1931) – Intra operative cholangiography. 
• Okuda (1973) – CHIBA needle for percutaneous 
Transhepatic Cholangiography. 
• Wildegans of Germany (1953) introduced modern 
choledochoscope. 
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• Shore and shore (1965) – Flexible Choledochoscope. 
• Yamakawa (1975) – Percutaneous Trans hepatic 
Cholangiography 
• McCune and Oi (1970) – ERCP 
• Kawai et al- Endoscopic papillotomy. 
• First laparoscopic CBD exploration by Philips Peterson. 
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Review of Literature II 
 
EMBRYOLOGY OF LIVER AND BILIARY TRACT 
Liver develops from an endodermal bud that arises from the 
ventral part of the junction between foregut and midgut. This bud 
grows into the ventral mesogastrium and passes into the septum 
transversum. This bud enlarges and divides into larger pars hepatica, 
and a smaller pars cystica. The pars hepatica divides into right and left 
parts and forms each lobe of liver. Sinusoids are formed from the 
mesenchyme of the septum transversum2. 
           Bile formation begins in third month of gestation. The bile is 
responsible for the black colour of the first stools (meconium). 
Gall bladder and Biliary passages: 
The Gall Bladder and cystic duct develops from the pars cystica 
which divides from pars hepatica. The bile duct develops from the 
proximal part of the hepatic bud. The bile duct opens into ventral 
aspect of the developing duodenum. As a result of differential growth 
of the duodenal wall, and as a result of the rotation of the duodenal 
8 
loop, the bile duct opens on the dorso-medial aspect of the duodenum 
along with the ventral pancreatic bud2. 
 
Gall Bladder: 
The gallbladder is 7-10 cm long and has a capacity of 30-50 ml. 
It is located on the visceral surface of the liver in a shallow fossa at 
the plane dividing the right lobe from the medial segment of the left 
lobe (the GB-IVC line). In other words, the gallbladder fossa is found 
at the junction of the quadrate lobe (segment IV) and the right lobe of 
the liver along the line of Rex. The gallbladder is separated from the 
liver by the connective tissue of Glisson's capsule. Anteriorly, the 
peritoneum of the gallbladder is continuous with that of the liver3,7 11 
The gallbladder can be divided into fundus, body, infundibulum, 
neck, and cystic duct. 
The fundus projects beyond the inferior margin of the liver, in 
the angle between the lateral border of the right rectus abdominis and 
the ninth costal cartilage. It is entirely surrounded by peritoneum3 11. 
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           The body lies in the fossa for the gall bladder on the liver. The 
upper narrow part of the body is continuous with the neck at the right 
end of the porta hepatis. The superior surface of the body is devoid of 
peritoneum, and is adherent to the liver. The inferior surface is 
covered with peritoneum, and is related to proximal part of transverse 
colon and first part of the duodenum. 
           The neck is the narrow upper end of the gall bladder. It first 
curves anterosuperiorly and then posteroinferiorly to become 
continuous with the cystic duct. Its junction with the cystic duct is 
marked by a constriction. The posteromedial wall of the neck is 
dilated to form a pouch called the Hartmann’s pouch which is directed  
downwards and backwards3,7 11.  
Cystic Duct: 
           Cystic duct is about 3 to 4 cm in length. It ends by joining with 
the common hepatic duct at an acute angle to form the common bile 
duct. The mucous membrane of the cystic duct forms a series of 5 to 
10 crescentic folds, arranged spirally to form the so-called “spiral 
valve” of Heister. This is not a true valve3 21. 
10 
  
 
 
 
 
 
 
 
 
 
Common Bile Duct367: 
The common bile duct begins at the union of the cystic and 
common hepatic ducts and ends at the papilla of Vater in the second 
part of the duodenum. It varies in length from 5 cm to 15 cm, 
depending on the actual position of the ductal union. In 22%, the 
common hepatic and cystic ducts, on average, run parallel for 17 mm 
before the ducts actually unite. The average diameter is about 6 mm 
The common bile duct can be divided into four portions or 
segments: supraduodenal, retroduodenal, pancreatic, and intramural. 
The supraduodenal portion of the common bile duct lies between the 
layers of the hepatoduodenal ligament in front of the epiploic foramen 
of Winslow, to the right or left of the hepatic artery, and anterior to 
the portal vein. Its length is 2-5 cm367. 
The distal part of the supraduodenal portion is related to the 
posterior superior pancreaticoduodenal (PSPD) artery, which has a 
retroduodenal location and which crosses the duct first anteriorly and 
then posteriorly. This artery is not to be confused with the 
supraduodenal artery, which also may pass anterior to the common  
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bile duct. In the majority of cases the retroportal artery joins the PSPD 
artery, but it may join the right hepatic artery directly and send 
branches to the common duct en route. The PSPD artery is easily 
injured while exploring the common duct3 11. 
If the junction of the cystic and common hepatic ducts is low, 
the supraduodenal segment is short or even absent. Large lymph 
nodes may be fixed to the right side of the supraduodenal segment. 
 
The retroduodenal portion of the common bile duct is between 
the superior margin of the first portion of the duodenum and the 
superior margin of the head of the pancreas. It is 1-3.5 cm long. The 
duct may be free or partially fixed to the duodenum11. 
The pancreatic portion of the common bile duct extends from 
the upper margin of the head of the pancreas to the point of entrance 
into the duodenum. It passes downward to the right, posterior to the 
pancreas or within the pancreatic parenchyma3 11 21. 
The intramural portion of the common bile duct takes an oblique 
path averaging 1.5 cm through the duodenal wall. Here it  
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receives the main pancreatic duct inferiorly. The two ducts usually lie 
side-by-side with a common adventitia for several millimetres. The 
diameter of both ducts decreases within the duodenal wall. The 
septum between the ducts is reduced to a thin mucosal membrane 
before the ducts become confluent3 11. 
 
            The terminal part of the bile duct is surrounded just above its 
junction with the pancreatic duct by a ring of smooth muscle that 
forms the sphincter choledochus. This sphincter is always present. It 
keeps the lower end of the bile duct in closed status. As a result, bile 
formed in the liver keeps accumulating in the gall bladder and also 
undergoes considerable concentration. When food enters the 
duodenum, especially a fatty meal, the sphincter opens and the bile 
stored in the gall bladder is poured into the duodenum3 6 8 24. 
            Another less developed sphincter, which is usually but not 
always present around the terminal part of the pancreatic duct, is 
called sphincter pancreaticus. A third sphincter surrounds the  
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hepatopancreatic ampulla and is called the sphincter ampullae. The  
sphincter ampullae may extend proximally to enclose the lower parts 
of bile and pancreatic ducts. 
          The sphincters named above are often referred to collectively as 
the sphincter of Oddi3 8 11. 
 
Blood supply: 
The cystic artery arises from the right hepatic artery as it crosses 
the calot’s triangle to the right of the common hepatic duct. The 
lymph node of Lund usually lies just superficial to the position of the 
cystic artery in the cystic triangle, and can be a good guide to finding 
and ligating it. Reaching the gallbladder behind the common hepatic 
duct, the cystic artery usually branches into an anterior superficial 
branch and a posterior deep branch. These branches anastomose and 
send arterial twigs to the adjacent liver. The cystic artery may arise 
from the left hepatic artery or the gastroduodenal artery11 24. 
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The extrahepatic bile ducts in most individuals are supplied 
from the cystic artery above and from the posterior superior 
pancreaticoduodenal artery below 
The epicholedochal arterial plexus of the CBD is derived from 
the retroduodenal or pancreaticoduodenal arteries. The collateral 
circulation is enhanced by two intramural plexuses. These may be 
compressed between the oedematous mucosa and the external tough 
fibrous coat in pathologic conditions such as cholangitis or common 
bile duct obstruction secondary to choledocholithiasis11 24 25. 
Veins: 
            The superior surface of the gallbladder is drained by multiple 
small veins passing through the gallbladder bed that breaks up into 
capillaries within the liver. They do not form a single "cystic vein." 
Veins from the hepatic surface drain directly into the liver. Veins on 
the inferior surface open directly or follow the hepatic ducts into the 
liver. From the peritoneal surface, one vein usually drains the fundus 
and body and other veins drain the neck and upper portions of the 
cystic duct as well as the hepatic ducts. These small veins enter the 
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liver together with ascending veins from the common bile duct. These 
veins rarely open into extra hepatic portal veins. This is not an 
important Porto systemic shunt3 11 24.  
Nerve Supply: 
• Coeliac plexus 
• Seven to nine thoracic sympathetic fibres 
             Pain from the gall bladder may travel along the vagus, the 
sympathetic nerves, or along the phrenic nerves. It may be referred to 
different parts through these nerves as follows3 24 25.  
1. Through the vagus to the stomach 
2. Through the sympathetic nerves to the lower pole of the 
scapula 
 Calot Triangle: 
               It is bounded, right side by the upper part of the gallbladder 
and cystic duct, left side by the common hepatic duct and superiorly 
by the inferior surface of the right lobe of the liver3 8 11 21. 
Histology: 
        The bile ducts are composed of an external fibrous layer of 
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connective tissue, a few thin smooth muscle layers (longitudinal, 
oblique, and circular), and an internal layer of mucosa of columnar 
epithelium. The gallbladder wall is formed, from external to internal, 
by the following layers: 
  Serosa 
  Adventitia 
 Fibro muscular layers 
Mucosa 
  Serosa is the typical visceral peritoneum formed by 
mesothelium on the surface with loose connective tissue directly 
beneath. Adventitia is a layer of dense connective tissue that is found 
external to the muscularis externa where the gallbladder is attached to 
the surface of the liver. The adventitia contains large blood vessels, 
autonomic fibres for innervation of muscularis externa and blood 
vessels, a rich lymphatic network, and a plethora of elastic fibre’s and 
adipose tissue3. 
          Fibro muscular layers comprise many elastic and collagen 
fibres among bundles of smooth muscle cells. No muscularis mucosa 
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or submucosa is found in the gallbladder. Mucosa is distinguished by 
having very tall, slender columnar epithelial cells. While no glands 
are found in the mucosa, this layer is thrown into elaborate folds 
which on first inspection give the impression of glands. These folds 
form deep diverticula of the mucosa and have been identified as 
"Rokitansky-Aschoff sinuses"; in some cases, these extend through 
the muscularis externa. Bacteria have been known to accumulate in 
these folds, and chronic inflammation may develop11 21. 
Physiology: 
 Bile produced by hepatocytes, drains into the hepatic canaliculi. 
It travels from the terminal bile ducts to the right and left hepatic 
ducts. Then it moves to the common hepatic duct. The majority of the 
bile goes from the common hepatic duct through the cystic duct to the 
gallbladder, drains to the common bile duct, and then to the 
duodenum. The remainder of the bile goes to the common bile duct, 
then to the duodenum, bypassing the gallbladder3 6 8. 
             Bile production is such that 250 ml to 1,500 ml of bile enters 
the duodenum each day. The gallbladder has a capacity ranging from 
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15 to 60 ml (average approximately 35 ml). The gallbladder 
concentrates bile by absorbing sodium, chloride, and bicarbonate ions 
and water such that bile salts can be concentrated 5 to 250 times. 
Potassium ions are concentrated as the water is absorbed; further 
concentration results from simple diffusion. Bile contains significant 
amounts of carbonate and calcium ions. The epithelium secretes 
hydrogen ions, and the carbonate ions are converted to bicarbonate. 
Calcium and bicarbonate ions are absorbed by the epithelial cells and, 
thus, calcium carbonate precipitation in the gallbladder is avoided9. 
                 The hormone cholecystokinin causes contraction of the 
gallbladder muscle, forcing bile out. Stimulation from the vagus nerve 
also causes the gallbladder to contract. The sphincteric apparatus of 
Oddi becomes inhibited in the presence of cholecystokinin and 
relaxes as a reaction to gallbladder contraction. All of these actions 
force bile into the CBDandintothe second part of duodenum3.  
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Anomalies of the Biliary Tract11 21 
Absence of the Gallbladder: 
Occasionally the gallbladder (and usually the cystic duct as 
well) is absent or vestigial. The absence must be confirmed by ruling 
out an intrahepatic gallbladder or a left-sided gallbladder.  
 
Multiple Gallbladders: 
               A double gallbladder in a human was found at autopsy in 
year 1674; the first such anomaly to be recorded from observation of  
a living patient was in 1911. Triple gallbladders can each have an 
individual cystic duct or all share the same duct. Variably, two of the 
gallbladders can share a duct, and the third have a separate duct2 11. 
Multiple gallbladders form a continuous spectrum of malformations, 
from an externally normal organ with an internal longitudinal septum 
to the most widely separated accessory gallbladders. For practical 
purposes, the anomalies can be categorized into six basic types,three 
types belong to the split primordium group and three belong to the 
accessory gallbladder group. All are described below2 21. 
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Split Primordium Group: 
In a split primordium, multiple gallbladder elements drain to the 
common bile duct by means of a single cystic duct. The three types 
follow. . 
"Y" duplication; 
 Two separate gallbladders are present. Two separate cystic 
ducts combined to form a common cystic duct. Then common cystic 
duct joins into the common bile duct2 11. 
Accessory Gallbladder Group 
 Ductular "H" duplication; 
            Common bile duct receives cystic duct and accessory cystic 
duct separately. This is the most frequent type. 
Trabecular duplication; 
 Rarely, the cystic duct is duplicated without duplication of the 
gallbladder. The duplicated cystic duct joins into the right hepatic 
duct. 
 Triple gallbladder; 
Various combinations may be present 
21 
Left-Sided Gallbladder: 
               Rarely, a gallbladder is found on the under surface of the left 
lobe of the liver. In such cases, the cystic duct enters the common bile 
duct from the left. There is no associated functional disorder2 11.  
Intrahepatic Gallbladder: 
              An intrahepatic gallbladder is submerged in the liver and 
gives the appearance of absence of the gallbladder. CT scan or 
ultrasonography may provide its only evidence. A high percentage of 
occurrences of lithiasis are associated with this anomaly2 11.  
Mobile Gallbladder: 
               At the opposite extreme from intrahepatic gallbladder is the 
occasional mobile gallbladder, attached to the liver by a mesentery. 
Such a gallbladder is susceptible to torsion and strangulation. 
Otherwise, it causes no symptoms. 
Variations and Anomalies of the Biliary Ducts 
Extra hepatic Biliary Atresia: 
              Congenital biliary atresia is the most serious malformation of 
the biliary tract. A short segment, an entire duct, or the whole system 
22 
may be atretic. All possible combinations may be encountered. The 
atretic duct may be hypoplastic, stenosed, or reduced to a fibrous band 
that is easily overlooked by the surgeon2 24 
Hepatic biliary Ductular atresias may be divided into three 
groups: 
              The first type includes patent proximal hepatic ducts and 
occluded distal ducts. Patency may occur in any portion of the right or 
left hepatic duct as it emerges from the liver. This atresia is called 
"correctable". 
             The second type includes occluded proximal ducts. No 
portion of the emerging hepatic duct is patent. This atresia is called 
"noncorrectable". 
             The third type includes the presence of intrahepatic atresia. In 
this form of atresia, the extrahepatic ducts may be present or absent. 
The mechanism of intrahepatic atresia remains obscure and the 
condition is as yet noncorrectable. It requires early liver 
transplantation2 3 11 21. 
 
23 
Congenital Dilatation of the CBD (Choledochal Cysts) 
                A local balloon-shaped or cylindrical enlargement of the 
common bile duct is probably congenital. Symptoms of obstruction 
are the result of the dilatation rather than its cause. The first 
classification of these dilatations is that of Alonso in 1959, who 
described three types of Choledochal cysts. In 1984, Todani 
described a modification of this system that included five types11 21. 
I-Solitary fusiform extrahepatic cyst. Single cystic dilatation of the                  
CBD (80-90% of cases) 
II-Diverticulum of the CBD, with normal size CBD (3%) 
III-Intraduodenal diverticulum/choledochocele. Cystic biliary 
dilatation     within the duodenal wall (5%) 
    IV- Any combination of multiple cysts, i.e., types I, II, III (10%) 
IVA-Cystic or fusiform dilatation of both intra and extra hepatic 
duct.Combination of types I and II 
IVB- Multiple extrahepatic cysts. Combination of type I with multiple 
intrahepatic cysts 
 V- Caroli's disease/multiple intrahepatic cysts (very rare) 
24 
The pancreaticocholedochal junction was abnormal in most of these 
patients.Type I is the most common (90-95%)11 21. 
Physiology9 21 
• Unconjugated bilirubin formed mainly in spleen by the 
breakdown of haemoglobin 
• It is insoluble and is transported in the plasma bound to albumin 
• Taken up by the liver by active transport, it is converted in the 
hepatocytes into conjugated bilirubin (water-soluble) 
• It is excreted into the bile canaliculi and via the main bile ducts 
into the duodenum 
• 10% of the unconjugated bilirubin is reduced to urobilinogen by 
small intestinal bacteria and is reabsorbed in the terminal ileum 
and then excreted in the urine (enterohepatic circulation) 
• 90% is converted by colonic bacteria to stercobilinogen, which 
is excreted in faeces. 
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Jaundice: 
         Jaundice or icterus a generic term used for yellow discoloration 
of the skin, mucous membrane or sclera caused by heterogenousgroup 
of disorders. Causes are divided into two categories cholestasis and 
mechanical obstruction 
 Surgical jaundice or obstructive jaundice occurs due to the intra or 
extra hepatic obstruction to the biliary flow6 7 8 
 
Causes of Obstructive Jaundice8 9 10 
• Intraluminal abnormalities of bile ducts: 
o Gallstones 
o Blood clot (Hemobilia) 
o Parasites (e.g. flukes) 
o Foreign body (e.g. Broken T tube) 
• Mural abnormalities of bile ducts: 
o Cholangiocarcinoma 
o Biliary atresia 
o Primary sclerosing cholangitis 
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o Primary biliary cirrhosis  
o Secondary biliary cirrhosis 
o Benign/Malignant stricture 
o Choledochal cyst 
• Extraneous compression of bile system: 
o Carcinoma head of pancreas 
o Periampullary carcinoma 
o Lymphadenopathy of porta hepatis nodes 
o Duodenal tumour / diverticulum 
o Chronic pancreatitis 
o Mirrizi’s syndrome 
o Pseudocyst of pancreas 
 
BENJAMIN’S CLASSIFICATION7 
 
Type 1 - Complete obstruction  
               Carcinoma head of pancreas 
               Common bile duct ligation 
27 
 Cholangiocarcinoma 
Parenchymal liver tumors (primary or secondary)   
Type 2 - Intermittent obstruction 
              Choledocholithiasis 
              Periampullary tumors 
              Choledochol cyst 
              Duodenal diverticula 
              Polycystic liver disease 
              Biliary parasites 
              Hemobilia 
Type 3 - Chronic Incomplete Obstruction 
              Stricture of the common bile duct 
Congenital 
Traumatic (iatrogenic) 
   Sclerosing cholangitis 
Post radiotherapy 
              Stenosis of biliary-enteric anastomosis 
28 
Sphincter of oddi stenosis 
 Cystic fibrosis 
 Chronic pancreatitis 
Type 4 - Segmental Obstruction 
              Traumatic 
              Intrahepatic stones 
              Sclerosing cholangitis 
              Cholangiocarcinoma  
Pathophysiology of obstructive jaundice7 9 
            Biliary obstruction produces local effects on the bile ducts that 
lead to derangements of hepatic function and ultimately to widespread 
systemic effects. Patients who are jaundiced are at increased risk of 
developing hepatic dysfunction, renal failure, cardiovascular 
impairments, nutritional deficiencies, bleeding problems, infections, 
and wound complications and of dying after surgery. 
Hepatobiliary Factors 
              With biliary obstruction, the bile canaliculi become dilated, 
and the microvilli become distorted and swollen. In patients with 
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long-standing obstruction, intra-hepatic bile ductule proliferation 
occurs with an increase in the length and tortuosity of the canaliculi. 
In the setting of partial or complete biliary obstruction as biliary 
pressure increases (up to 30 cm H2O), the tight junction between 
hepatocytes and bile duct cells are disrupted, resulting in an increase 
in the bile duct and canalicular permeability, this results in an 
inflammatory response followed by increased fibro genesis with 
deposition of type I collagen in the portal triads7 8 
          Impairment of macrovascular and microvascular perfusion of 
the liver has been reported in patients with obstructive jaundice. This 
alteration of hepatic perfusion may explain the increase risk of 
hepatocellular dysfunction when performing liver resections in 
patients with obstructive jaundice.  
          When biliary pressure increases to greater than 20 cm H2O, 
hepatic bile secretion is diminished, as a result excretory products of 
the hepatocytes reflux directly into the vascular system leading to 
systemic toxicity. In addition hepatic metabolic and synthetic 
functions are also depressed. 
30 
         Kupffer cells demonstrate decreased endocytosis, phagocytosis, 
clearance of bacteria and endotoxin. 
Cardiovascular Factors 
           Following hemodynamic and cardiac disturbances have been 
reported in experimental animals with obstructive jaundice. 
1.  Decreased cardiac contractility 
2.  Reduced left ventricular pressure 
3.  Impaired response to β-agonistic drugs 
4.  Decreased peripheral vascular resistance 
                 The combination of depressed cardiac function and 
decreased total peripheral resistance most likely makes jaundiced 
patients more susceptible to the development of post-operative shock 
than non-jaundiced patients7 8 9.  
Renal Factors 
          Important factors that may be involved in the development of 
renal failure in obstructive jaundice include 
1.  Depressed cardiac function 
2. Hypovolemia 
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3. Endotoxemia 
Coagulation Factors 
                The most frequently observed clotting defect is 
prolongation of the prothrombin time due to low levels of vitamin K 
dependent factors. This problem results from impaired vitamin K 
absorption from the gut, secondary to lack of intestinal bile. This 
coagulopathy is usually reversible by parenteral administration of 
vitamin K7 8. 
Immune System Factors 
              Jaundiced patients have numerous defects in cellular 
immunity that make them more prone to infection. Absence of bile 
from the intestinal tract also plays a role in the infectious 
complications seen in patients with biliary tract obstruction, due to the 
increased bacterial translocation from the gut in the setting of bile 
duct obstruction. 
             Cholangitis results from the combination of two factors: 
significant bacterial concentrations in the bile and biliary obstruction. 
The most common organisms recovered from bile in patients with 
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cholangitis include Escherichia coli, Klebsiella pneumoniae, 
Enterococci and Bacteroides fragilis. The fever and the chills 
associated with cholangitis are the result of systemic bacteremia 
caused by cholangio-venous and cholangio-lymphatic reflux that 
occurs when the intra-biliary pressure rise൐20 cm of H2O7 8. 
Wound Healing Factors 
              Prolonged wound healing and a high incidence of wound 
gapping and incisional hernias have been noticed in patients 
undergoing surgery to relieve obstructive jaundice. Patients with 
obstructive jaundice have decreased activity of the enzyme propyl-
hydroxylase in their skin. Propyl hydroxylase is important for the  
proline amino acid residues incorporation into collagen7 8 9. 
Clinical Presentation 
             Three main symptoms that are seen in patients with biliary 
tract obstruction are; jaundice, pain and fever. In addition to that, 
patients also give history of biliary colic, passing clay colored stools, 
generalized pruritus, vomiting, hematemesis, and anorexia and weight 
loss. 
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            Classically, pain is a discriminating feature in jaundiced 
patients. Patients with biliary obstruction resulting from the tumor 
usually have painless jaundice, whereas patients with an acute attack 
of pain or a long history of intermittent episodes of jaundice 
accompanied by pain usually have gall stone disease, but up to 60-70 
% of patients with gall bladder carcinoma and carcinoma head of 
pancreas present with epigastric, right upper quadrant or back pain. In 
the event of cholangitis, intermittent jaundice is accompanied by 
rigors and fever (Charcot’s triad), and in severe cases is also 
associated with mental obtundation and shock (Reynolds’s pentad) 7. 
 
COURVOISIER’S LAW 
            IN THE PRESENCE OF JAUNDICE, AN ENLARGED 
GALL BLADDER IS UNLIKELY TO BE DUE TO GALL 
STONES11 21 28. 
There may be several exceptions to this 
1. Double impaction of stone 
2. Mucocele of gall bladder 
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3. Pancreatic calculi in ampulla of Vater 
4. Carcinoma gall bladder 
5. Oriental cholangiohepatitis 
Investigations: 
Liver Function Tests7 8 
 Alkaline phosphatase (ALP): 
                      Elevation of ALP in hepato-biliary disease is due to 
increased synthesis by the biliary Ductular endothelium, perhaps 
stimulated by bile acids and it usually precedes the onset of symptoms 
and jaundice. Slight or moderate rise in ALP occurs in parenchymal 
liver disease. However, a marked rise ALP occurs in obstructive 
jaundice. Simultaneous determination of GGT and serum bile acids 
confirms that the rise in ALP is due to obstructive jaundice. The most 
sensitive indicator of extrahepatic biliary obstruction, regardless of 
the etiology or location is serum ALP. The level of ALP is not an 
indicator of function and has no prognostic significance. It is also 
useful for follow up in who have had surgery to relieve biliary tract 
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Obstruction, and is also elevated when there is segmental or partial 
obstruction of the biliary tree, this is especially useful, as the bilirubin 
is often normal in these patients8 28. 
Gamma-glutamyltranspeptidase (GGT) 
        GGT increases markedly (up to 40-fold) in mechanical bile duct 
obstruction; it has been proposed that SGPT/GGT ratio is better able 
to differentiate between obstructive jaundice and hepatitis than ALP 
or any of the enzymes taken alone8 9 
Coagulation Profile 
              The liver is the main site of synthesis of most of the 
coagulation factors, abnormalities of which can be determined by 
measuring the prothrombin time (PT) which measures the rate of 
prothrombin conversion to thrombin in the presence of 
thromboplastin, calcium and requires the integrity of the most of the 
vitamin K dependent clotting factors (factors II,VII,IX,X). Vitamin K 
is a fat soluble vitamin, absorption of which requires presence of bile 
salts in the intestine, which is absent in patients with biliary tract 
obstruction. So PT is prolonged in patients with obstructive jaundice  
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But parenteral administration of Vitamin K should reverse the 
abnormal coagulation. Administration of fresh frozen plasma also 
corrects the PT8 9 10. 
Tumour Markers 
Carbohydrate antigen (CA 19-9); 
            The CA19-9 antigen is a sialated oligosaccharide formed on 
the circulating mucin in the cancer patients. It is most widely used 
Tumour marker in pancreatic cancer. It has a reported sensitivity and 
specificity of about 80-90% and is suggestive, rather than 
confirmatory, of the diagnosis of pancreatic malignancy. It also 
elevated in acute or chronic biliary diseases. CA 19-9 is neither 
sensitive nor specific for pancreatic cancer because 15% of patients 
do not secrete CA 19-9 owing to their Lewis antigen status. But in 
patients with Gall bladder cancer CA 19-9 is a more sensitive marker 
with sensitivities and specificities of approximately 75% at a level 
greater than 20 U/ml8 9. 
Ultrasonography (USG): 
           It is the most useful non-invasive initial investigation for 
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distinguishing medical from surgical cause of jaundice and to 
differentiate extrahepatic from intrahepatic biliary obstruction. USG 
is initial screening information in patients with suspected obstructive 
jaundice. Is is more sensitive in detecting gall stones (95%) and 
intrahepatic obstruction, but less sensitive for detecting CBD stones 
(50%) and pathology and lesions of the pancreas. USG evidence of 
CBD dilatation of more than 7 mm has been described as the best 
predictor of Choledocholithiasis7 8 9. 
Contrast enhanced Computed Tomography (CECT): 
              CT scan has limited value in diagnosing CBD stones 
(sensitivity of 76-90%), But is more specific in detecting the level of 
obstruction and cause of obstruction than USG. It is better in 
evaluating operability, pre-operative staging and CT Angiography 
gives better assessment of invasion or compression of vessels. The 
“workhorse” in the work-up of patients suspected of a pancreatic or a 
Periampullary neoplasm is a multi-detector spiral CT and is probably 
the single most useful diagnostic and staging modality as it provides 
complete and accurate information of the lesion and its adjacent 
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vascular structures like portal vein, SMA, SMV, splenic vein and 
celiac axis and also about involvement of Periampullary lymph nodes 
and retroperitoneal structures. CT scan also done in all patients 
suspected gall bladder cancer. 
   The CT criteria used to define a potentially resectable pancreatic 
cancer are 
• Without any extra-pancreatic spread 
• Intact fat plane between growth and the SM-PV 
• Absence of growth infiltrating or encircling the SMA, celiac or 
hepatic arteries 
Spiral CT (Helical) Scan improves biliary tract imaging by producing 
multiple overlapping images in a shorter time than conventional CT 
scan6 7 8. 
Magnetic Resonance Cholangiopancreaticography (MRCP): 
                MRCP takes advantages of the fact that bile has high signal 
intensity on T2 weighted images, whereas the adjacent structures do 
not enhance and can be suppressed during image analysis. Common 
bile duct stones are seen as low intensity signal defects surrounded by  
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high intensity bile. Stones as small as 2mm can be detected even in 
the absence of biliary dilatation. MRCP is very useful for diagnosis of 
benign conditions like Choledochal cyst and benign biliary strictures. 
In hilar cholangiocarcinoma MRCP is the principal imaging 
radiographic technique and provides an accurate assessment of biliary 
ductal anatomy and the type and extent of biliary block. MRCP also 
has a high sensitivity and specificity for diagnosing etiology of 
obstruction. MRCP also combines with ERCP in differentiating 
benign from malignant strictures7 8. 
Endoscopic Ultrasonography (EUS): 
             EUS is being increasingly used for patients with low bile duct 
obstruction particularly due to Periampullary carcinoma. The 
advantages includes better local staging, possibility of tissue diagnosis 
using guided FNA, and increased accuracy for diagnosing nodal 
disease. The disadvantages include expense, and operator 
dependence. EUS has more sensitivity in detecting bile duct stones. 
Compared with ERCP, EUS is semi-invasive with almost no 
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procedure related complications and negligible failure rate. EUS  
offers higher resolution than MRCP and is therefore better able to 
detect small stones. 
Endoscopic Retrograde Cholangiopancreaticography (ERCP): 
          ERCP, a technique used to evaluate and treat biliary and 
pancreatic disorders, but with the advent and easy availability of 
MRCP use of ERCP as diagnostic investigation for the pancreato-
biliary disorders has decreased significantly. Although it is still used 
occasionally in the diagnosis of Periampullary or ampullary 
malignancies by obtaining tissue biopsy and brush cytology. As  
therapeutic procedure ERCP is widely used in the following 
conditions6 7 8 10 
• Removal of CBD stones 
• Pre surgical biliary decompression in patients with 
cholangitis 
• Endoscopic palliation of obstructive jaundice in 
unresectable Periampullary carcinoma. 
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Hepatobiliary Scintigraphy:- 
Hepatobiliary Iminodiacetic Acid (HIDA Scan) 
                      When there is a clinical suspicion of bile duct injury 
after surgery, HIDA scanning should be one of the first tests 
considered. The degree of leak can be assessed, and this can help 
triaging of patients with bile leak to conservative or operative repair. 
It is also useful in assessing the efficacy of biliary drainage7 28. 
Percutaneous Transhepatic Cholangiography (PTC): 
                PTC is a widely available imaging technique for the 
detection of ductal calculi especially intra hepatic ductal calculi  
because of generally better ductal filling. PTC provides a better 
delineation of the type of stricture and intrahepatic biliary anatomy 
than MRCP but the disadvantage is that it cannot image any excluded 
ductal system. It is an important investigation for diagnosis and 
preoperative evaluation of hilar cholangiocarcinoma7 8 9  
Positron Emission Tomography: 
             It is being used more frequently in carcinoma Gall Bladder 
and Hilar Cholangiocarcinoma to identify patients with distant 
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metastasis that would contraindicate surgical resection.Results 
superior in imaging, diagnosis, and staging.False positive in 
Xanthogranulomatous cholecystitis.Sensitivity 75% % Specificity 
88% in carcinoma Gall Bladder.It also important to detect incurable 
stage. 
Staging Laparoscopy: 
Advancement in laparoscopic skill has coincided with the 
increased use of laparoscopy for diagnosis and treatment of biliary 
tract disorders. It is most effective when used in conjunction with  
laparoscopic ultrasound in the staging and operative management of  
biliary malignancies. Intraoperative ultrasound is now used frequently 
to further evaluate intrahepatic lesions, assess resectability, and 
determine involvement of vascular structures. Although the need for 
laparoscopy may have diminished as a result of advancements in 
radiologic techniques like CT, laparoscopy still best identifies 
micrometastases much beyond the discrimination of the CT scan; in 
addition, biopsy of micrometastases can be undertaken with the 
laparoscope7  8 10. 
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Preoperative preparation of patient with obstructive jaundice7 8 28; 
• Correction of anemia by pre-operative packed cell 
transfusion 
• Replenishment of depleted liver glycogen reserve due to 
hepatocellular dysfunction by oral or intravenous 
administration of dextrose 
 • Correction of fluid and electrolyte deficits 
•Coagulation profile altered due to Vit Kdeficiency as result 
of obstructive jaundice; the same may becorrected by 
parenteral administration of vitamin K for 3-5 days before 
surgery. 
• Fresh frozen plasma may be needed to correct coagulation 
derangements in cases of severe hepatocellular dysfunction. 
• Patients with obstructive jaundice are more prone for renal 
failure in the post-operative period so adequate hydration should 
be maintained in the peri-operative period. 
• Broad spectrum prophylactic antibiotics with gram negative 
cover based on previous culture sensitivity reports. 
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• Patient may require pre-operative biliary drainage (PBD) either 
by ERC and stenting or percutaneous biliary drainage in the setting 
of cholangitis, severe malnutrition, grossly elevated bilirubin (>20-
25mg %). Routine PBD in absence of the above indications not 
recommended as it significantly increases post-operative morbidity 
Surgical Management; 
Choledocholithiasis29 31 32: 
1. Endoscopic sphincterotomy, stone extraction/CBD stenting 
followed by Lap/Open cholecystectomy 
2. Lap/Open Cholecystectomy followed by Lap/Open CBD 
Exploration 
 
CBD Exploration7 832: 
               First surgical exploration of the CBD was done in 1980 by 
Ludwig Courvoisier. 
Indications  
y PREV.HISTORY OF JAUNDICE / CHOLANGITIS / 
PANCREATITIS 
y PALPABLE STONES IN CBD 
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y DILATED CBD 
y MULTIPLE SMALL STONE 
 
Lap CBD exploration most commonly done 
Either trancystic or transductal  
Transductal  
• Stones >6mm 
• Intrahepatic stones 
• Cystic duct diameter<4mm 
• Cystic duct entrance either posterior or distal  
T-Tube7 834 
• For decompression if CBD not cleared 
• Later study of biliary system 
• Access to biliary system for recurrent stones 
Placing ‘T’ Tube: 
• Shorten limbs & remove part of wall 
• Allows sphincter edema to settle 
• 14 F size 
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• Tract for future intervention if retained stones are 
detected 
• T tube cholangiogram 7 – 8 days 
• If normal – remove > 12 days 
• Retained stone – keep ‘T’ tube 
• Intervention 5 – 6 wks. Later 
Retained / Recurrent Stones28 32: 
Retained - detected in a short time after surgery                            
Recurrent - diagnosed months or years later 
 
Choice of treatment 
¾ Clinical presentation 
¾ Presence of T tube 
¾ Endoscopic expertise 
T tube in situ: 
 OBSERVATION 
 MECHANICAL EXTRACTION- BURHENNE 
TECHNIQUE27 
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 DISSOLUTION-Mono Octanoin instillation 
 CHOLEDOCHOSCOPIC CLEARANCE 
 LITHOTRIPSY 
Endoscopic treatment32 28: 
• ERCP/Endoscopic sphincterotomy 
85 – 95% success 
Difficult  
• Stones >2cms 
• Distal stricture 
• After Billroth II anastomosis 
If non operative treatment fails 
OPEN OR LAPARASCOPIC CBD EXPLORATION 
 
3. Biliary drainage procedures: 
Surgical biliary drainage procedures must be considered in the 
following situations 
 • Multiple stones 
• Incomplete removal of all stones 
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• Impacted, irremovable distal bile duct stones 
• Markedly dilated common bile duct 
• Distal bile duct obstruction from tumour or stricture 
• Reoccurrence after previous bile duct exploration    
Methods of surgical drainage include 
•      Trans duodenal sphincteroplasty 
• Choledochoduodenostomy  
• Choledochojejunostomy 
Choledochol cyst6 7 8 9 
     Type-1: solitary fusiform extra-hepatic cyst:   
                        Excision + roux-en-y   hepaticojejunostomy 
     Type 2:- Diverticular dilation of extra hepatic biliary tree 
                         Excision of dilated diverticulum 
                         Closure over T-tube 
    Type3:-Cystic dilation of intraduodenal portion of CBD 
(choledochocele)  
                        Choledochocele <3cms- Endoscopic sphincterotomy 
Choledochocele >3cms- Trans duodenal excision 
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Type 4:- 
           4A: Multiple cysts both in extra & intrahepatic biliary tree 
                            Extra hepatic: excision with hepatico jejunostomy 
Intra hepatic: hepatic resection 
           4B: Multiple extra hepatic cysts 
                             Excision with hepatico jejunostomy 
Type 5:- 
             Intrahepatic multiple cysts associated with cirrhosis or 
periportal fibrosis 
Confined to single lobe: Hepatic lobectomy 
               Multilobar associated with hepatic failure, cirrhosis, and 
portal hypertension: liver transplantation 
Lilly Technique7 8: 
 If cyst is adherent to portal vein, complete full thickness 
excision is impossible. That part of the cyst wall over portal vein is 
left behind and the mucosa of that part should be removed. 
Postoperative complications: 
• Cholangitis 
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• Biliary stone formation 
• Anastomotic stricture 
• Intrahepatic bile duct dilatation 
• Malignancy 
Biliary strictures 
Vast majority of biliary strictures are a consequence of preventable 
iatrogenic injury to extra-hepatic biliary tract 
Causes of Benign Biliary Stricture6 7 8 9 10: 
• Congenital-Biliary Atresia 
• Bile Duct injury 
 Post-operative 
   Blunt or Penetrating trauma 
  Endoscopic biliary procedures 
• Inflammatory 
                CBD stones 
                Chronic pancreatitis 
                Recurrent cholangitis 
                Parasitic infections 
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• Primary Sclerosing Cholangitis 
• Radiation injury 
• Papillary stenosis 
Distinction between benign and malignant stricture: 
 
      Benign    Malignant 
Age  Usually young   Elderly 
Duration   Variable Short Duration 
Cholangitis    Usual Unusual 
Depth of jaundice     Variable >15 mg% 
Weight loss/Anorexia    Rare   Common 
Imaging of stricture  Long stricture with 
regular margins and 
sectoral involvement 
          Short stricture,  
irregular margins, 
thick walled. 
 
Management: 
ERC & Stenting 
Roux-en-Y hepaticojejunostomy 
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Biliary stricture with Portal Hypertension8 9: 
         This is a difficult group of patients with high rate of 
complications and mortality. If serious bleed is encountered than a 
splenorenal shunt should be done before definitive procedure. 
 
Mirrizi’s syndrome: 
Inflammation & resultant bile duct stricture caused by bouts of 
cholecystitis due to gall bladder lying alongside the common hepatic 
duct6 7 8 10 
Type I: mechanical compression or an inflammatory stricture of 
extra hepatic biliary system 
Type II: Stone eroding the duct  cholecystocholedochal fistula 
 
Management: 
   Type I Mirrizi’s:-  
Cholecystectomy 
Care to be taken while dissection 
Late strictures (rare) - Roux-en-Y hepaticojejunostomy 
53 
Type II Mirrizi’s:- 
Partial cholecystectomy 
Cuff of remaining GB – for repair over T tube 
 
Periampullary Carcinoma8 9 28 
• Pancreaticoduodenectomy (Whipple Procedure) 
• Traverso and Longmire pylorus-preserving 
pancreaticoduodenectomy (PPPD). 
Palliative Treatment:Non-operative 
Biliary decompression 
• Endoscopic with stenting  
• Percutaneous-Transhepatic approach 
 Duodenal obstruction  
• Obstruction relieved by inserting expandable stent 
by endoscopic method 
Pain 
• Orally or transcutaneously administered analgesics 
• Percutaneous image guided celiac plexus block 
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Palliative Treatment:  
Operative 
             Biliary tract decompression 
• Cholecystojejunostomy 
• Choledochojejunostomy 
Duodenal obstruction 
• Side-to-side gastrojejunostomy  
Pain 
• Injection of Ethanol into the celiac plexus 
Indications for preoperative biliary drainage: 
• Bilirubin > 20-25 mg% 
• Sepsis 
• Severe malnutrition 
• Severe cardiopulmonary disease 
• Hepatorenal failure 
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Postoperative complications7 8 28: 
• Pancreatic Fistula (2-24%) 
• Intra-abdominal abscess (1-12%) 
• Post pancreatectomy hemorrhage (1-10%) 
• Delayed gastric emptying (10-15%) 
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Analysis of  
100 cases of 
Obstructive jaundice 
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MATERIALS AND METHODS 
DESIGN 
This is a prospective descriptive study. Study population has 
been selected after necessary exclusion criteria have been applied. 
SETTING 
The study is done at a tertiary care centre namely, Govt. Rajaji 
Hospital, Madurai in all seven General Surgery wards and the Dept. 
of Surgical Gastroenterology. The period of study is from 
June 2010 to June 2012. 
POPULATION / PARTICIPANTS / SAMPLE SIZE 
              A random selection of 100 patients admitted in surgical 
wards within June 2010 to June 2012 has been done. 
INCLUSION CRITERIA 
1. Patientswithjaundice due to either intra or extra hepatic   
biliary tract obstruction  
2. Patients with malignancy outside the Hepatobiliary system or 
pancreas producinginfiltration of biliary tree or secondaries in 
porta hepatis. 
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EXCLUSION CRITERIA 
1. Patients with haemolytic and hepatocellular jaundice. 
 
          On admission a detailed history and clinical examination were 
made. Routine basic biochemical investigations and Liver Function 
Test were done in all the patients followed by real-time 
ultrasonography. Followed by appropriate investigations were carried 
out.  
            In patients with stone disease, stricture and Choledochal cyst 
MRCP were carried out to assess the biliary ductal anatomy. In all 
patients with malignant obstructive jaundice CECT scan of 
abdomen was carried out to assess the operability. 
If operable lesion were detected patients underwent a careful 
preoperative preparation. Histopathological examination was 
conducted in relevant patients. They were followed in the post-
operative period and subsequently after discharge. 
         If inoperable lesions were detected patient underwent palliative 
procedures. 
59 
The various causes for the obstructive jaundice in our hospital were 
analysed. Acomparison was made with other studies regarding the 
incidence, sex distribution, mode of presentation,prognosis and 
survival. The results were compared and graphically represented and 
a conclusion was arrived from it. 
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TABLES AND CHARTS 
 
Table 1.Age distribution: 
Age Group 
       (In yrs.) 
Number 
    of Patients 
Percentage 
       % 
        21-30 10          10% 
        31-40 12          12% 
        41-50 25          25% 
        51-60 30          30% 
        61-70 18          18% 
        71-80 4            4% 
        81-90 1             1% 
 
          More common in the fifth and sixth decade of life 
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Age Distribution 
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Table 3.Etiology of Obstructive Jaundice: 
 
 
S 
No 
ETIOLOGY OF OBSTRUCTIVE      
JAUNDICE 
No OF 
PATIENTS 
1 
2 
3 
4 
5 
6 
7 
8 
Choledocholithiasis 
Carcinoma Head of Pancreas 
Periampullary Carcinoma 
Stricture 
Cholangiocarcinoma 
Carcinoma Gall Bladder 
Choledochol cyst 
Carcinoma Stomach with porta hepatis   
lymph node metastasis 
51 
24 
10 
5 
4 
3 
2 
1 
    100 
 
     Most common cause of obstructive jaundice is 
Choledocholithiasis(51%). 
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Table 4.Bilirubin Levels: 
 
S. No Bilirubin level (mg %) Percentage of Patients 
  1       <5             8  
  2 5-10            42 
  3 11-20            28 
  4   21-30            12 
  5 >31            10 
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Table 5: Choledocholithiasis: 
 
S 
No 
         Management No of  
patients 
% of 
Patients
  1 ERCP  Stone Retrieval/Stenting    17    33 
  2 CBDE/ T Tube       8    16 
  3 CBDE/CDD    24    47 
  4 CBDE/CDJ      2      4 
 
                                               Total No of patients: 51 
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Table 6. Carcinoma Head of Pancreas: 
 
S No Management No of 
Patients 
% 0f 
Patients
 1 Whipples procedure     7   29 
 2 Triple Bypass   15   63 
 3 Double Bypass     1     4 
 4 Palliative stenting     1     4 
 
                                                  Total no of Patients: 24 
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Table 7: Periampullary Carcinoma: 
 
S No Management No of 
Patients 
%  of  
Patients
 1 Whipples procedure     2   20 
 2 Triple bypass     8   80 
 
                                           Total No of Patients: 10 
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20%
80%
PERIAMPULLARY CARCINOMA
Whipples
Triple Bypass
RESULTS AND OBSERVATIONS 
   We studied 100 patients of Obstructive jaundice in our wards in 
Govt. Rajaji Hospital, Madurai, from June 2010 to June 2012. 
          Among 100 patients 50 were male and 50 were female. The 
mean age group was 51.29 yrs. The age range from 21 to 84 years and 
more common in fifth and sixth decade of life. 
       The average duration of illness was 4.8 months, the range being 
10 days to 12 months. The mean duration of hospital stay was 14 days 
that range between 4 days to 45 days. 
         All patients had icterus (100%). 65% of patients had pain 
abdomen, of which 42% of patients had typical colicky type of 
abdominal pain. 44% of patients had fever, of which 31% of patients  
were associated with chills and rigors. 
          Symptoms of complete biliary tract obstruction, clay coloured 
stools and high coloured urine presented in 30% of patients. Cachexia  
was seen in 29% of patients.  
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           Gall Bladder was palpable in 44% of patients, of which most 
were due to pancreatic and Periampullary malignancies.  
         The mean serum bilirubin value was 14.5 mg%. The range 
between 2.0-36 mg%. The average ALP value was 420.85 IU, and the 
range between 108-1032 IU. Urine examinations showed absent in 
urobilinogen in 42 % of patients. Serum albumin range was 2.5-5.5 
gm. %. In More than 50 % of patients, the A: G ratio was reversed.  
            Ultra sonogram revealed IHBR dilatation in 90% of pts. 
Therapeutic ERCP done in 17 patients of CBD stone disease. After 
therapeutic ERCP laparoscopic/open cholecystectomy was done in all 
17 patients.  
          Preoperatively all patients received three doses of Vit K and 
fresh frozen plasma in selective patients. Coagulation profile was 
monitored by measuring PT and INR. 
          In our study we observed the most common cause of biliary 
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tract obstruction was CBD stones (51%).Among these most of the  
patients were females (34 pts., 67%). The second most common cause 
was carcinoma head of pancreas (24 %), followed by Periampullary 
carcinoma (10%). Among these the Ca head of Pancreas was more 
common in male population (83%). More common in fifth decade of 
life. 
             Other rare causes of obstructive jaundice observed in our 
study were Stricture CBD (5%), Cholangiocarcinoma (4%), 
Carcinoma Gall Bladder (3%), Choledochol cyst (2%) and carcinoma 
Stomach with porta hepatis metastasis (1%). 
             CBD stones are treated by therapeutic ERCP/Stenting, CBD 
Exploration and biliary enteric anastomosis or T Tube Drainage. 
Among these CDD was most commonly done (47%). 
             Among the malignant causes, curative resection (Whipples 
procedure) was done in 7 patients of Ca Head of Pancreas (29%) and 
2 patients of Periampullary carcinoma (20%). Most of the patients 
with Ca head of Pancreas were locally advanced and treated by 
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Palliative bypass procedure 63%). 
               11 patients expired in our study group. All expired patients 
had biliary tract obstruction due to malignant aetiology. The most 
common complication noticed in operated patients was biliary fistula. 
Fistula is more common following palliative procedure for malignant 
aetiology. Patients with benign diseases are on regular follow up and 
they doing well. 
           The histopathology report of pancreatic cancer consists of well 
differentiated adenocarcinoma (30%), moderately differentiated in 
(30%) and poorly differentiated (40%). 
                None of the patients with cholangiocarcinoma and 
carcinoma Gall bladder were operable. Biliary obstructions in these 
patients were relieved by ERCP/Stenting. 
              In our study 5% of patients were due to stricture in the biliary 
tract. Of these 4 patients had Hilar stricture, for which Roux n Y 
Hepaticojejunostomy was done. 1 patient had terminal CBD stricture 
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and CBD stone, for which CBD exploration 
andCholedochoduodenostomy was done. In our study 80% of the 
stricture was due to previous surgery/endoscopic procedure. 
Out of 100 patients, 2% patients were due to Choledochol cyst. For 
which Total cyst excision and biliary enteric anastomosis was done. 
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DISCUSSION 
             Jaundice is a most challenging problem for any person, more 
so when people are ignorant of the on-going severe underlying 
disease.            
          Because of the self-medication and the natural treatment the 
presentation is very late in suffered patients. Specific symptoms will 
not occur in early stage of the disease. It will occur after the disease 
becomes locally advanced or involving adjacent vital structures.  
            Comparing the other studies done elsewhere, the observation 
in our study implies, the overall incidence of obstructive jaundice was 
same in both male and female. The mean age of incidence of surgical 
jaundice is 51 yrs. 
But the incidence of Choledocholithiasis was more common in 
females. The most common cause of malignant obstructive jaundice 
was Carcinoma Head of Pancreas, which is more common in male 
population especially in fifth and sixth decade of life. 
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            The second most common cause of malignant obstructive 
jaundice was peri ampullary carcinoma, which was equally affected in 
male and female population. 
            The lowest age noted for a female patient is 21 yrs., and for 
male is 23 yrs. both were diagnosed to be Choledochol cyst. 
               Comparing with S.Agal et al of Mumbai who studied 62 
cases of malignant aetiology and M.Kannan et al of Chennai who 
studied 455 cases of both benign and malignant etiology there is more 
or less equal age incidence. 
                The gallbladder felt in 44% of our patients while in 
Benjamin series it was palpable in 50% of the icteric patients and 
62.20% of those with pancreatic malignancies. 
             Evaluation of obstructive jaundice is common but challenging 
radiological problem. The aim of the imaging is to diagnose biliary 
obstruction by identifying dilatation of intra and extra-hepatic biliary 
channels; to delineate the level of obstruction. 
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          Ultrasonography is widely available, non-invasive and radiation 
free imaging modality. It is the initial modality for the detection of 
obstruction in the biliary tree. 
              Ultrasound was performed in all our patients. It showed 
dilatation of intrahepatic biliary radicles in 84% of patients. 
                  CBD stones are treated by therapeutic ERCP/Stenting, 
CBD Exploration and biliary enteric anastomosis or T Tube Drainage. 
Among these CDD was most commonly done (47%) 
                    Comparing to other studies of Benjamin and Popper, our 
study revealed same curative rates in the management of other benign 
extrahepatic biliary tract obstructive lesions such as stricture of the 
Common Bile Duct and Choledochal cyst. 
            In our study, we did not perform any method of preoperative 
biliary drainage for any amount of bilirubin levels mainly in patients 
with malignant cause of biliary obstruction since various studies have 
shown no difference in the survival benefits with this procedure 
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We had 11 deaths in the follow up and those under evaluation. These 
patients were mainly in their advanced stage of their disease and the 
underlying pathology was mostly advanced carcinoma CBD, 
carcinoma of the gallbladder, Pancreatic and peri ampullary 
malignancies.  
            Present study was compared with those of other studies. It has 
been summarized below: 
Table 8: Comparison of presenting symptoms and signs 
 Agarwal et al Nadkarni et al Our study 
Icterus         100         100        100 
Pain abdomen         79.1         53.8          42 
Itching           50         73.1          48 
Fever         12.5         53.8           44 
Anorexia         70.9          88.5           58 
Clay-coloured 
stools  
        41.1          92.3           30 
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           As can be seen jaundice was the main presenting 
symptom/sign in the study of Agarwal and Nadkarni et al. 
Nausea/Vomiting and pain abdomen was the other major presenting 
symptoms. In the present study it is nausea vomiting followed by 
itching, fever and pain abdomen. 
Table 9: Comparison of etiological distribution 
 Nadkarni et 
al(24) 
Kar et al(129) Present 
study(100) 
CBD Stones 9 32         51 
Stricture 1 4           5 
Malignancy 
Pancreas/Biliary 
Tract 
14 93         41 
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CONCLUSION 
• Common presentation of surgical jaundice is jaundice 
• Palpable Gall bladder indicates the etiology to be malignant 
• The most common cause of obstructive jaundice was 
Choledocholithiasis followed by carcinoma head of pancreas 
and Periampullary carcinoma. 
• Choledocholithiasis was more common in females. 
• Carcinoma head of Pancreas was more common in male 
population & most of them in the late fifth and sixth decade of 
life. 
• Biliary tract obstruction due to metastasis is not uncommon. 
• USG followed by MRCP/ERCP and CT scan are the 
investigation of choice. 
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• Patients with benign pathology had a better outcome and cure 
rate 
• Patients with malignant pathology were mostly inoperable, and 
underwent palliative bypass procedures. 
• The preoperative biliary drainage does not have any survival 
benefit 
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 ABBREVIATIONS 
 
 
CBD - Common Bile Duct 
IHBR - Intra Hepatic Biliary Radicals 
ERCP - Endoscopic Retrograde Cholangio Pancreatography 
MRCP - Magnetic Resonance Cholangio Pancreatography 
PTC - Percutaneous Transhepatic Cholangiography 
CBDE - Common Bile Duct Exploration 
CDD - Choledochoduodenostomy 
CDJ - Choledochojejunostomy 
HJ - Hepaticojejunostomy 
 
 
 
 
 
 
 
PROFORMA 
 
Name:                                  IP Number:                                                                 
Age:                                                Sex: 
Address:                                         Unit: 
 
Socio Economic Status: 
Date of Admission:                    Date of Discharge: 
Symptoms:                                 Duration of illness: 
          Jaundice 
          Abdominal pain 
          Fever 
          Clay coloured stools 
          High coloured urine 
          Anorexia 
          Melena 
          Steatorrhoea 
          Pruritus 
          Loss of weight & appetite 
Past History: 
          Chronic calcific pancreatitis, Diabetes mellitus, previous 
surgery, Blood Transfusion, Previous Drug intake 
 
 Personal History: 
Dietary habit, Alcoholism, Smoking and Exposure to chemical 
carcinogen. 
Family History: 
            Jaundice and malignancy 
General Examination: 
    Built:                        Pallor:                               Hydration: 
    Icterus:                     Scratch marks:              Pedal oedema: 
   BP:                             Pulse rate: 
Signs: 
        Palpable Gall Bladder 
        Hepatomegaly 
        Tenderness 
        Ascites 
       Abdominal mass 
Signs of Liver cell failure: 
 Investigations:  
             Liver function tests 
             Renal function tests 
             Complete haemogram 
Bleeding time, Clotting time, PT, INR 
             Urine bile salt, bile pigment, urobilinogen 
             USG, CT scan and MRCP 
Preoperative preparation: 
            Vit K, IV Fluids, Antibiotics, Fresh Frozen Plasma. 
Preoperative Decompression Procedures: 
 
Surgical Procedure: 
               Curative: 
               Palliative: 
 
Per-Op Findings: 
 
Metastasis:  
            Regional lymph nodes, liver, peritoneum and other sites 
 
Post-Operative recovery & Complications: 
 
Histopathological Report: 
 
Duration of Hospital Stay: 
 
 
 
                                 MASTER CHART 
 
S 
No 
       Name  A/S   IP No    Symptoms  G
B  
Diagnosis  Treatment  Outcome 
1  Nagendran  30/m  68573     J/P/F/A   ‐  CBD Calculus  CBDE/CDD  Uneventful  
2  Kalidas  23/m  63172     J/P ‐ Choledochal cyst Excision/HJ  Uneventful
3  Rajathi  70/f  59180  J/CS/LOW  +  Ca Head of Pancr  Trip bypass     ‐                    
4  Lakshmi  51/f  54504    J/P/A/CS  ‐  Stricture CBD  Rouen HJ  Uneventful 
5  Saradha  36/f  49057   J/M/LOW  +  Peri ampullary Ca  Trip bypass  Expired 
6  Mayandi  40/m  50593 J/P/F/A ‐ CBD Calculus CBDE/T tub  Uneventful
7  Sudha  21/f  43832     J/P  ‐  Choledochal cyst  Excision/HJ  Uneventful 
8  Muthu  60/m  36632   J/M/CS/F  +  Peri ampullary Ca  Trip bypass    ‐ 
9  Irulayee  50/F  34168 J/M/CS/F + Peri ampullary Ca Trip bypass  Expired
10  Andammal  45/f  74199   J/I/CS/HU  ‐  Stricture CBD  Roux enYHJ  Uneventful 
11  Vedham  61/m  00180    J/P/F/A  ‐  CBD Calculus  CBDE/CDD  Biliary Fist 
12  Veeraiah  46/m  07500    J/P/F/A  ‐  CBD Calculus  CBDE/T tub  Uneventful 
13  Mandiradev  70/m  10314  J/P/A/CS + GB Carcinoma ERCP Stent  2* Liver
14  Rasyabegam  36/f  56088    J/P/A/CS  ‐  Cholangio Ca  ERCP Stent  Cholangitis 
15  Pappa  60/f  32800  J/P/I/LOW  +  Peri ampullary Ca  Whipples  Uneventful 
16  Chellammal  59/f  36793    J/P/LOW  +  Ca Head of Pancr  Trip bypass  Biliary fist 
17  Fathimuthu  50/f  22197 J/P/F/A/CS ‐ CBDstone/Strictur CBDE/CDD  Uneventful
18  Stellamarry  27/f  10283  J/A/LOW  +  Ca Head of Pancr  Trip bypass    ‐ 
19  Palaniyama  50/f  75959     J/P/F/I  ‐  CBD Stone  CBDE/T tub  Uneventful 
20  Shanthi  35/f  68928    J/P/A/I  +  Ca Gall Bladder  Pallia stent   Expired 
21  Ayyakalai  50/m  38291 J/P/A/CS ‐ Stricture CBD RouenY HJ  Uneventful
22  Pottiyammal  58/f  34503   J/M/A/CS  +  Peri ampullary Ca  Trip bypass     ‐ 
23  Paulsamy  60/m  23482   J/M/A/CS  +  Peri ampullary Ca  Trip bypass      ‐ 
24  Malliga  53/f  25956 J/P/LOW + Ca Head of Pancr Trip bypass  Expired
25  Manjula  50/f  19536 J/P/F/A ‐ CBD Stones CBDE/T tub  Uneventful
26  Valli  42/f  14200   J/P/A/CS  ‐  Stricture CBD  CDD  Uneventful 
27  Saroja  40/f  08401  J/P/F/A  ‐  CBD Stones  CBDE/CDD  Uneventful 
28  Gowri  50/f  13512 J/P/A/I ‐ CBD Stones CBDE/CDD  Uneventful
29  Sundar raj  54/m  10252  J/LOW/CS  +  Ca Head of Pancr  Trip bypass     ‐ 
30  Padmavathy  33/f  14243   J/P/F/A  ‐  CBD Stones  CBDE/CDD  Uneventful 
31  Suganthi  28/f  93039  J/P/F/A  ‐  CBD Stones  CBDE/T tub  Uneventful 
32  Lakshmi  30/f  21493 J/P/A/I ‐ CBD Stones ERCP Stent  Uneventful
33  Syed  35/m  23685   J/P/F/I  ‐  CBD Stones  CBDE/T tub  Uneventful 
34  Balakrishnan  40/m  24329   J/P/F/A  ‐  CBD Stones  CBDE/CDD      ‐ 
35  Dhancika  23/f  26161   J/P/F/A  ‐  CBD Stones  ERCP  Uneventful 
36  Ramamari  50/f  26700 J/P/A/CS ‐ Stricture CBD RouenY HJ  Uneventful
37  Ganamary  63/f  25188   J/P/F/I  ‐  CBD Stones  ERCP  Uneventful 
38  Revathi  22/f  20887   J/P/F/I  ‐  CBD Stones  CDBE/CDD  Uneventful 
39  Pappathi  55/f  25636   J/P/A/I  ‐  CBD Stones  CBDE/CDJ  Uneventful 
40  Nallathangai  46/f  24762 J/P/A ‐ CBD Stones ERCP  Uneventful
41  Rajagopalan  68/m  32218   J/P/A  ‐  CBD Stones  CBDE/CDD  Uneventful 
S 
No 
   Name  A/S  IP No  Symptom G
B 
     Diagnosis  Treatment   Outcome
42  Chellammal  64/f  26119 J/P/A/I ‐ CBD Stones CBDE/CDD  Uneventful
43  Velu  60/m  35581  J/LOW/CS  +  Ca Head of Pancr  Trip bypass  expired 
44  Alagar  60/m  41430   J/P/F/I  ‐  CBD Stone  ERCP  Uneventful 
45  Kokila  32/f  43850   J/A/P/I  ‐  CBD Stones  ERCP  Uneventful 
46  Nagaiah  58/m  43048 J/P/F/A ‐ CBD Stones CBDE/CDD  Uneventful
47  Mohan  65/m  47199   J/P/F/I  ‐  CBD Stones  ERCP  Uneventful 
48  Pandy  45/m  49455   J/P/F/A  +  CBD Stones  CBDE/CDJ  Uneventful 
49  Veeranam  67/m  41941   J/P/F/A  ‐  CBD Stones  CBDE/CDD  Uneventful 
50  Savithri  53/f  51102 J/P/F/I ‐ CBD Stones ERCP  Uneventful
51  Meenatchi  45/f  50289   J/P/F/A/I  +  CBD Stones  CBDE/CDD  Uneventful 
52  Muthu  77/f  19321   J/P/F/I  ‐  CBD Stones  CBDE/CDD  Uneventful 
53  Janaki  72/f  04232   J/P/F/A  ‐  CBD Stones  CBDE/CDD  Uneventful 
54  Eswari  45/f  58842 J/P/A/F ‐ CBD  Stones ERCP  Uneventful
55  Jeyalakshmi  73/f  62038   J/P/F/I  +  CBD Stones  ERCP  Uneventful 
56  Patchiammal  60/f  58842   J/P/A/F/I  ‐  CBD Stones  CBDE/CDD  Uneventful 
57  Mayilthai  60/f  64201 J/P A/F/I ‐ CBD Stones ERCP  Uneventful
58  Kamatchi  60/f  40837   J/A/CS/I  ‐  Cholangio Ca  Pallia Stent  Expired 
59  JhonKennady  42/m  47182  J/M/A/CS  +  Peri ampullary Ca  Trip bypass  Uneventful 
60  Deivanai  64/f  79853   J/P/F/A/I  ‐  CBD Stones  CBDE/CDD  Uneventful 
61  Sudharsan  60/m  51922 J/LOW/CS + Ca Head of Pancr Trip bypass  Expired
62  Alagar  67/m  69352  J/A /CS/M  +  Peri ampullary Ca  Trip bypass  Uneventful 
63  Vadivammal  51/f  82030   J/P/F/A/I  ‐  CBD Stones  ERCP  Pancreatitis 
64  Marry stella  53/f  01979   J/P/A/F/I  ‐  CBD Stones  CBDE/CDD  Uneventful 
65  Palaniappan  54/m  69352 J/LOW/CS ‐ Ca Head of Pancr Whipples  Biliary fist
66  Rathinam  42/m  12532  J/P/A/CS/I  ‐   CBD Stones  CBDE/CDD  Uneventful 
67  Perumal  69/m  71811  J/V/LOW/m ‐  Ca Stomach  ERCP Stent  Expired 
68  Irulayee  25/f  03995  J/P/F/A/I  ‐  CBD Stones  ERCP  Uneventful 
69  Malaisamy  63/m  73128 J/LOW/CS/I + Ca Head of Pancr Trip bypass     ‐
70  Ganapathy  65/m  03204  J/P/F/A/I  ‐  CBD Stones  CBDE/CDD  Uneventful 
71  Kanaga  45/f  07802  J/F/A/I  ‐  CBD Stones  CDDE/CDD  Uneventful 
72  Subburaj  48/m  59384 J/LOW/CS ‐ Ca Head of Pancr Whipples  Expired
73  chittammal  45/f  07902  J/P/A/F/I  ‐  CBD Stones  CBDE/T tub  Retained St 
74  Muniyandi  55/m  19826  J/A/LOW  +  Ca Gall Bladder  Stenting     ‐ 
75  Murugan  55/m  16479  J/A/LOW/I  +  Ca Head of Pancr  Doublbypas  Uneventful 
76  Veeraiah  45/m  12453 J/LOW/CS + Ca Head of Pancr Trip bypass  Liver failure
77  Murugesan  55/m  62232  J/LOW/A/I  ‐  Ca Head of Pancr  Whipples  Uneventful 
78  Lasu  70/m  65765  J/LOW/CS  +  Ca Head of Pancr  Trip bypass  Biliary fist 
79  Chandiran  40/m  67195  J/LOW/CS/I  ‐  Ca Head of Pancr  Whipples  Uneventful 
80  Raj  75/m  70517 J/A/I/CS ‐ Cholangio Ca ERCP Stent  Expired
81  Govindaraj  67/m  45222  J/P/A/F/I  ‐  CBD Stones  ERCP  Cholangitis 
82  Prakasam  55/m  51314  J/LOW/CS  +  Ca Head of Pancr  Trip bypass  Uneventful 
83  Ramuthai  70/f  28624  J/A/LOW/I  ‐  Cholangio Ca  ERCP Stent  2* Liver 
84  Vijayalaksmi  52/f  45423 J/P/F/A/I ‐ CBD Stones CBDE/CDD  Uneventful
85  Senthil latha  30/f  48139  J/P/F/A/I  ‐  CBD Stones  ERCP Stent  Uneventful 
86  Nandhagopal  59/m  54006  J/LOW/CS  ‐  Ca Head of Pancr  ERCP  DVT/Death 
87  Sappani  43/m  46230 J/P/LOW/I + Ca Head of Pancr Trip bypass  Uneventful
88  Kamatchi  46/f  45578  J/CS/LOW  +  Ca Head of Pancr  Trip bypass  Uneventful 
89  Manokaran  45/m  41505  J/P/F/A/I  ‐  CBD Stones  CBDE/CDD  Uneventful 
S 
No 
   Name  A/S  IP No    Symptom G
B 
    Diagnosis Treatment  Outcome
90  Kamatchi  40/f  39894 J/M/CS/HU + Peri ampullary Ca Whipples  Uneventful
91  Vellaisamy  41/m  19329  J/LOW/A/I  ‐  Ca Head of Pancr  Whipples  Pancreatitis 
92  Lakshmanan  61/m  32229  J/P/F/A/I  ‐  CBD Stones  ERCP  Uneventful 
93  Ramasamy  58/m  27282  J/P/A/I  ‐  CBD Stones  CBDE/CDD  Uneventful 
94  Natarajan  84/m  27041 J/P/A/I + CBD Stones ERCP  Cholangitis
95  Arikesavan  64/m  16748  J/P/A/F  ‐  CBD Stones  CBDE/T tub  Uneventful 
96  Pitchai  60/m  75701  J/LOW/CS/I  +  Ca Head of Pancr  Trip bypass  Uneventful 
97  Karupu  40/m  76525  J/LOW/CS  ‐  Ca Head of Pancr  Whipples  Uneventful 
98  Mahalingam  63/m  50330 J/P/LOW/I + Ca Head of Pancr Trip bypass  Uneventful
99  Karunanithi  45/m  66171  J/M/A/HU  ‐  Peri ampullary Ca  Trip bypass  Biliary fistu 
100  kannan  52/m  52066  J/LOW/CS  ‐  Ca Head of Pancr  Whipples  Uneventful 
 
 
                   J‐Jaundice                                                 LOW‐Loss of Weight 
                   CS‐Clay coloured stool                             HU‐High Coloured Urine 
                   P‐Pain                                                          A‐Anorexia 
                   F‐Fever                                                         I‐Itching 
                   M‐Melena                                                   GB‐Gall Bladder                            
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